Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 2 of 3: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20257)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Erlotinib | 10 | uM | 9 | 625.00 | 414.82 | 424.17 | 828.71 | 0.5151 | 0.0260 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 9 | 625.00 | 414.82 | 609.50 | 828.71 | 0.7383 | 0.4751 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 9 | 625.00 | 414.82 | 964.83 | 828.71 | 1.1703 | 1.3666 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 9 | 625.00 | 414.82 | 834.17 | 828.71 | 1.0135 | 1.0470 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 9 | 625.00 | 414.82 | 744.83 | 828.71 | 0.9003 | 0.8014 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 9 | 625.00 | 414.82 | 619.50 | 828.71 | 0.7496 | 0.4978 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 9 | 625.00 | 414.82 | 508.50 | 828.71 | 0.6130 | 0.2186 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 9 | 625.00 | 414.82 | 454.00 | 828.71 | 0.5527 | 0.1035 |
| SK-BR-3 | Lapatinib | 1 | uM | 9 | 625.00 | 414.82 | 415.67 | 828.71 | 0.5025 | -0.0006 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 9 | 625.00 | 414.82 | 406.67 | 828.71 | 0.4914 | -0.0243 |
| SK-BR-3 | Lapatinib | 10 | uM | 9 | 625.00 | 414.82 | 322.33 | 828.71 | 0.3903 | -0.2262 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 9 | 625.00 | 414.82 | 940.33 | 828.71 | 1.1348 | 1.2759 |
| SK-BR-3 | Linsitinib | 0.01 | uM | 9 | 625.00 | 414.82 | 1038.67 | 828.71 | 1.2584 | 1.5416 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 9 | 625.00 | 414.82 | 946.50 | 828.71 | 1.1437 | 1.2973 |
| SK-BR-3 | Linsitinib | 0.1 | uM | 9 | 625.00 | 414.82 | 857.83 | 828.71 | 1.0397 | 1.0934 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 9 | 625.00 | 414.82 | 984.67 | 828.71 | 1.1944 | 1.4142 |
| SK-BR-3 | Linsitinib | 1 | uM | 9 | 625.00 | 414.82 | 786.00 | 828.71 | 0.9478 | 0.8924 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 9 | 625.00 | 414.82 | 747.50 | 828.71 | 0.9037 | 0.8087 |
| SK-BR-3 | Linsitinib | 10 | uM | 9 | 625.00 | 414.82 | 717.33 | 828.71 | 0.8683 | 0.7399 |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 9 | 625.00 | 414.82 | 537.00 | 828.71 | 0.6514 | 0.3000 |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 9 | 1250.00 | 830.55 | 2036.33 | 1981.73 | 1.0276 | 1.0435 |
| SK-BR-3 | 17-AAG | 0.0001 | uM | 9 | 1250.00 | 830.55 | 2198.00 | 1981.73 | 1.1092 | 1.1725 |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 9 | 1250.00 | 830.55 | 1880.17 | 1981.73 | 0.9497 | 0.9200 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 9 | 1250.00 | 830.55 | 1984.83 | 1981.73 | 1.0015 | 1.0014 |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 9 | 1250.00 | 830.55 | 1885.50 | 1981.73 | 0.9525 | 0.9237 |